Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;30(6):587-93.
doi: 10.1097/HCO.0000000000000218.

Arterial tortuosity in genetic arteriopathies

Affiliations
Review

Arterial tortuosity in genetic arteriopathies

Shaine A Morris. Curr Opin Cardiol. 2015 Nov.

Abstract

Purpose of review: Arterial tortuosity is emerging as a common feature in genetically mediated thoracic aortic disease that may be prognostic. This review will summarize recent literature on arterial tortuosity in the setting of genetic arteriopathies.

Recent findings: Although arterial tortuosity has been primarily described in Loeys-Dietz syndrome due to TGFBR1 and TGFBR2 mutations and in arterial tortuosity syndrome due to SLC210A mutations, recent studies that use quantitative measures of tortuosity suggest that tortuosity is present in many other genetic conditions associated with aortic dilation and dissection. The mechanisms of the development of tortuosity in these disorders are not fully understood, but are founded in the concept that there is abnormal, pathologic arterial lengthening in a fixed space, resulting in more tortuous vessels. Further studies suggest that patients with increased arterial tortuosity are at increased risk of adverse cardiovascular events, including aortic surgery, aortic dissection, and death.

Summary: Arterial tortuosity is commonly present in genetically mediated aortic disease. Given the suboptimal performance of aortic dimension alone in predicting aortic dissection, quantification of tortuosity may augment the current algorithms for determining risk in patients with aortic disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None

Figures

Figure 1
Figure 1
Examples of vertebral artery tortuosity in Marfan syndrome with FBN1 mutation (A) and Loeys-Dietz syndrome with a TGFBR2 mutation (B).
Figure 2
Figure 2
Calculating the vertebral artery tortuosity index (VTI). This example uses a volume-rendered 3D magnetic resonance angiogram. Actual length (A and C) and straight length (B and D) of each vertebral artery are measured from the origin of vessel to the vertebral level C2 before the normal posteriolateral bend of the vessel. For both vertebral arteries, the distance factor is calculated: (actual/straight length−1)*100. The maximum distance factor of the two vessels is the VTI. In this example of a patient with Loeys-Dietz syndrome, the left vertebral artery distance factor is ((131.1/83.6)−1)*100=57. This can be thought of as 57% excess length of the vessel. The right distance factor is ((108.6/73.0)−1)*100=49, or 49% excess length. Therefore this patient’s VTI is 57%. Images complements of Alex Dodd, Texas Children’s Hospital.
Figure 3
Figure 3
Calculating the aortic tortuosity index (ATI), per Franken et al., International Journal of Cardiology 2015 from a 3D computed tomography angiogram. ATI is calculated as the ratio of aortic length (actual length) to geometric length (straight length). The aortic length (left side of image) was defined as the length of a centerline through the entire aorta (from annulus to aortic bifurcation) created by manually placed seeding points through the lumen of the aorta using post-processing software. Geometric length is the Cartesian distance between its 2 endpoints (added in smaller image on right, overlying the centerline). Aortic tortuosity index (ATI) is measured by dividing aortic length by geometric length. In this example in a patient with significant aortic tortuosity, aortic length = 367.2 mm, geometric length = 174.9 mm, ATI = 2.10. Images complements of Alex Dodd, Texas Children’s Hospital.

References

    1. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006 Aug 24;355(8):788–98. - PubMed
    1. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, et al. Nature Genetics. 4. Vol. 38. Nature Publishing Group; 2006. Apr, Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome; pp. 452–7. - PubMed
    1. Morris SA, Orbach DB, Geva T, Singh MN, Gauvreau K, Lacro RV. Circulation. 4. Vol. 124. Lippincott Williams & Wilkins; 2011. Jul 26, Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders; pp. 388–96. - PubMed
    1. van de Laar IMBH, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JMA, et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nature Genetics. 2011 Feb;43(2):121–6. - PubMed
    1. van der Linde D, van de Laar IMBH, Bertoli-Avella AM, Oldenburg RA, Bekkers JA, Mattace-Raso FUS, et al. Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants. Journal of the American College of Cardiology. 2012 Jul 31;60(5):397–403. - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources